High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence

Journal of Epidemiology and Community Health

Volumn 52, Issue 11, 1998, Pages 707-715

  Masiá, Rafel ^a   Pena, Araceli ^b   Marrugat, Jaume ^b   Sala, Joan ^a   Vila, Joan ^b   Pavesi, Marco ^b   Covas, Maribel ^b   Aubó, Clara ^b   Elosua, Roberto ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DRUG; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; HEALTH RISK; MEDICAL GEOGRAPHY; REGIONAL PATTERN; RISK FACTOR;

ADULT; AGE; AGED; ANGINA PECTORIS; ANTHROPOMETRY; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR RISK; EPIDEMIOLOGICAL DATA; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LIPID BLOOD LEVEL; MALE; MEDICAL RECORD; NORMAL HUMAN; QUESTIONNAIRE; SEX; SMOKING; SPAIN; STATISTICAL ANALYSIS;

EID: 0031720698     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.52.11.707     Document Type: Article

References (37)

1. Olalla MT, Almazán J, Sierra MJ, et al. Mortalidad por enfermedad isquémica del corazón. Boletín Epidemiológico Semanal 1997;22:177-88.
2. Pérez G, Pena A, Sala J, et al. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in the province of Gerona, Spain, 1990 to 1992. Int J Epidemiol 1998;27;599-604.
3. Banegas JR, Villar F, Pérez C, et al. Estudio Epidemiológico de los Factores de Riesgo Cardiovascular en la población española de 35 a 64 años. Rev Sanid Hig Publica (Madr) 1993;67:419-45.
4. Segura A, de Mateo S, Gutierrez J. Epidemiología de los Factores de Riesgo Cardiovascular en un área rural de la región de Castilla la Mancha. Revista Latina de Cardiología 1986;8:377-85.
5. Rodriguez Pérez JC, Calonge Ramirez S, et al. Prevalencia de los factores de riesgo de cardiopatía isquémica en la isle de Lanzarote. Med Clin (Barc) 1993;101:45-50.
6. Martinez MA, Bueno A, Fernandez MA, et al. Prevalencia de factores de riesgo cardiovascular en población laboral. Med Clin (Barc) 1995;105:321-6.
7. Institut d'Estadistica de Catalunya. Cens de població 1991. Barcelona: Institut d'Estadística de Catalunya, 1992.
8. Prineas RJ, Crow RS, Blackburn H. The Minnesota code. Manual of electrocardiographic Findings. Boston: John Wright,1982.
9. Covas MI, Martí S, Sentí M, et al. Evaluación de un método inmunoturbidimétrico para la determinación de la concentración sérica de lipoproteina(a). Clinica e Investigación en Arteriosclerosis 1995;8:15-20.
10. World Health Organisation. MONICA manual. Geneva: World Health Organisation, 1992.
11. Joint National Committe on detection, evaluation and treatment of high blood pressure. The fifth report of the Joint National Committe on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153: 154-83.
12. Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular survey methods. Geneva: World Health Organization, 1982.
13. Taylor HL, Jacobs DR, Schucker B, et al. A questionnaire for the assessment of leisure time physical activities. J Chron Dis 1978;31:741-55.
14. Elosua R, Marrugat J, Molina L, et al. Validation of the Minnesota leisure time physical activity questionnaire among Spanish men. Am J Epidemiol 1994;139:1192-209.
15. Waterhouse JAH, Muir C, Correa P, et al. Cancer incidence in five continents. Lyon: IARC Scientific Publications no 15, 1976:456.
16. Kannel WB, Gordon T. The Framingham study. An epidemiologic investigation of cardiovascular disease. Section 30. Some characteristics related to the incidence of cardiovascular disease and death: 18-year follow-up. Publication 74-599. Washington DC: United States Government Printing Office, 1974.
17. Kannel WB. Factores de riesgo en la enfermedad coronaria: experiencia del seguimiento durante tres decades del estudio Framingham. Hipertension y Arteriosclerosis 1989;1:77-86.
18. Lindblad U, Rastam L, Ryden L, et al. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ 1994;308:681-6.
19. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. BMJ 1994;308:367-73.
20. Muldoon MF, Manuck SD, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-14.
21. Tomás-Abadal L, Varas-Lorenzo C, Bernades-Bernat E, et al. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population. The Manresa study, Spain. Eur Heart J 1994;15:1028-36.
22. Liga Española pare la lucha contra la Hipertensión arterial. Consenso para el control de la hipertensión arterial en España. Madrid: Ministerio de Sanidad y Consumo, 1990.
23. Tresserras R, Pardell H. Prevalencia e importancia sanitaria de la hipertension arterial. Ann Med Intern (Madrid) 1990; 7:1-6.
24. The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Q 1988;41: 115-40.
25. Rosseneu M, Fruchart JC, Bard JM, et al. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary - heart disease and in control subjects. The EARS study. European Atherosclerosis Research Group. Circulation 1994;89:1967-73.
26. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex and menopausal status plasma lipoprotein (a) levels. The Framingham Offspring Study. Circulation 1993;87: 1135-41.
27. Meade TW. Epidemiology of atheroma, thrombosis and coronary heart disease. In: Born Gustav VR, Schwartz CJ, eds. New horizons in coronary heart disease. Texas: Current Science, 1993.
28. Sigurdsson E, Thorggeirsson G, Siggvaldason H, et al. Prevalence of coronary heart disease in Icelandic men, 1968-1986. The Reykjavik study. Eur Heart J 1993;14: 584-91.
29. Krogh V, Trevisan M, Panico S, et al. Prevalence and correlates of angina pectoris in the Italian nine communities study. Epidemiology 1991;2:26-32
30. Reunanen A, Aromaa A, Pyorola K, et al. The social insurance institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand 1983;673(suppl):1-120.
31. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-90.
32. ERICA Research Group. Prediction of coronary heart disease in Europe. The second report of the WHO-ERICA Project. Eur Heart J 1991;99:721-4.
33. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-90.
34. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation 1994;90:583-612.
35. Banegas JR, Alberdi JC, Rodríguez-Artalejo F, et al. Análisis edad-período-cohorte de la mortalidad por cardiopatía isquémica en España. 1965-1985. Gac Sanit 1992;6:97-104.
36. Artaud-Wild SM, Connor SL, Sexton G, et al. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. Circulation 1993;88:2771-9.
37. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.